National Oxygen Limited Announces Preferential Issue of Equity Shares
National Oxygen Limited announced on March 20, 2026, that its Board of Directors approved the issuance of up to 9,50,000 equity shares with a face value of Rs.10 each on a preferential basis. The shares will be issued to Saraf Housing Development Private Limited, a company forming part of the Promoter Group, at a price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.The company also appointed CA S Dehaleesan (Registered Valuer number: [IBBI/RV/04/2019/11659]) as the Registered Valuer for determining the price for the preferential issue and opened a separate bank account for the purpose.
The Board meeting commenced at 4:00 P.M. and concluded at 4:30 P.M.
| S.No | Particulars | Details |
|---|---|---|
| 1 | Type of securities proposed to be issued | Equity Shares |
| Type of issuance | Preferential allotment | |
| Total number of securities proposed to be issued | Issue of up to 9,50,000 (Nine Lakh Fifty Thousand) Equity Shares, having a face value of Rs.10/- (Rupees Ten Only) each, at a price not less than the price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 ('SEBI ICDR Regulations'), on a Preferential Basis to Saraf Housing Development Private Limited, a Company forming part of the Promoter Group of the Company | |
| Names of the Investor | Saraf Housing Development Private Limited (Promoter) |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: